These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7542328)

  • 1. The mammography and prostate-specific antigen controversies: implications for patient-physician encounters and public policy.
    Brett AS
    J Gen Intern Med; 1995 May; 10(5):266-70. PubMed ID: 7542328
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Public knowledge of benefits of breast and prostate cancer screening in Europe.
    Brenner H; Heywang-Köbrunner S; Becker N
    J Natl Cancer Inst; 2010 Mar; 102(5):356; author reply 356-7. PubMed ID: 20075365
    [No Abstract]   [Full Text] [Related]  

  • 3. To screen or not to screen: What is the question?
    Aronowitz R
    J Gen Intern Med; 1995 May; 10(5):295-7. PubMed ID: 7542330
    [No Abstract]   [Full Text] [Related]  

  • 4. [Counseling for cancer screening. Offer the facts instead of false promises].
    Klein F
    MMW Fortschr Med; 2010 Nov; 152(47):14-7. PubMed ID: 21226371
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving screening for cancer in the primary care setting. Where do we need to go and how can we get there?
    Atkins D
    J Gen Intern Med; 1996 Sep; 11(9):563-4. PubMed ID: 8905510
    [No Abstract]   [Full Text] [Related]  

  • 6. Rational computed tomography screening in 2003.
    Forster BB; Mayo JR
    Can Assoc Radiol J; 2003 Feb; 54(1):14-7. PubMed ID: 12625078
    [No Abstract]   [Full Text] [Related]  

  • 7. Current controversies in screening: cholesterol, breast cancer, and prostate cancer.
    Sox HC
    Mt Sinai J Med; 1999 Mar; 66(2):91-101. PubMed ID: 10100412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment and screening in The Netherlands: case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy.
    Banta HD; Oortwiin W
    Int J Technol Assess Health Care; 2001; 17(3):369-79. PubMed ID: 11495380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oncological screening in postmodern era].
    Berrino F
    Epidemiol Prev; 2000; 24(1):15. PubMed ID: 10748543
    [No Abstract]   [Full Text] [Related]  

  • 10. [Screening for cancer].
    Caicoya Gómez-Morán M
    Aten Primaria; 1995 Oct; 16(7):441-4, 446-52. PubMed ID: 7495955
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention.
    Eur J Cancer; 2000 Aug; 36(12):1473-8. PubMed ID: 10930794
    [No Abstract]   [Full Text] [Related]  

  • 12. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.
    Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L
    Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of preventive technologies in Germany: case studies of mammography, prostate cancer screening, and fetal ultrasound.
    Perleth M; Busse R; Gibis B; Brand A
    Int J Technol Assess Health Care; 2001; 17(3):329-37. PubMed ID: 11495377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of health technology assessment on preventive screening in Belgium: case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy.
    Vermeulen V; Coppens K; Kesteloot K
    Int J Technol Assess Health Care; 2001; 17(3):316-28. PubMed ID: 11495376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The accuracy and effectiveness of routine population screening with mammography, prostate-specific antigen, and prenatal ultrasound: a review of published scientific evidence.
    Woolf SH
    Int J Technol Assess Health Care; 2001; 17(3):275-304. PubMed ID: 11495374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography, routine ultrasonography in pregnancy, and PSA screenings in Italy.
    Favaretti C; De Pieri P
    Int J Technol Assess Health Care; 2001; 17(3):358-68. PubMed ID: 11495379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer: to screen or not to screen?
    Oncology (Williston Park); 1997 Mar; 11(3):325-6, 329-30. PubMed ID: 9109125
    [No Abstract]   [Full Text] [Related]  

  • 18. Physician-patient discussions of controversial cancer screening tests.
    Dunn AS; Shridharani KV; Lou W; Bernstein J; Horowitz CR
    Am J Prev Med; 2001 Feb; 20(2):130-4. PubMed ID: 11165455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
    Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
    J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: 4. Screening.
    Meyer F; Fradet Y
    CMAJ; 1998 Oct; 159(8):968-72. PubMed ID: 9834724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.